Stefan Michelfelder

Title: Innovations by Inventor Stefan Michelfelder

Introduction

Stefan Michelfelder is a notable inventor based in Denzlingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides for therapeutic applications. With a total of two patents to his name, Michelfelder's work is recognized for its potential impact on medical treatments.

Latest Patents

Michelfelder's latest patents focus on polypeptides designed to inhibit complement activation. The first patent describes a polypeptide that includes a C3 convertase effector domain, a C5 convertase effector domain, and an optional terminal complex inhibitory effector domain. This polypeptide is resistant to deregulation by physiological FHR-Proteins and features a dimerization motif, enhancing its therapeutic use. The second patent mirrors the first, emphasizing the innovative approach to complement activation inhibition.

Career Highlights

Throughout his career, Stefan Michelfelder has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Greenovation Biotech GmbH and Eleva GmbH. His experience in these organizations has contributed to his expertise and the development of his patented innovations.

Collaborations

Michelfelder has collaborated with various professionals in his field, including Karsten Häffner and Jakob Körbelin. These collaborations have likely enriched his research and development efforts, fostering a productive environment for innovation.

Conclusion

Stefan Michelfelder's contributions to biotechnology through his patents on polypeptides for inhibiting complement activation highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.